LTBR Stock Cash Flow Statements

Lightbridge Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Lightbridge Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2024-03-31	2023-12-31	2023-09-30	2022-12-31	2022-09-30	2021-12-31	2021-09-30	2020-06-30	2020-03-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-03-31	2008-09-30	2008-06-30	2008-03-31

operating activities
net income	-2,819,584	-2,370,014	-1,839,828	-1,908,156	-2,037,530	-2,301,325	-1,912,255	-2,132,106	-2,264,086	-1,671,689	-2,003,585	-1,683,758	-2,076,978	-1,522,461	852,602	-997,130	-787,935
adjustments to reconcile net income to net cash from operating activities
common stock issued for services		15,000	15,000	15,000	15,000	209,994	15,000
stock-based compensation	456,904	355,830	300,729	228,337	175,659	525,910	54,180	6,085	6,085
changes in operating assets and liabilities
prepaid expenses and other current assets	-194,796	45,340	103,216	190,655	103,420	133,759	142,250	90,000	-297,281	-139,534	286,422	-101,428	291,188	-387,189	100,545	16,027	-28,123
prepaid project costs and other long-term assets	3,375	3,375	3,375
accounts payable and accrued liabilities	676,095	-389,313	282,920	-840,055	707,725	-921,344	568,770	408,245	135,394
net cash from operating activities	-1,878,006	-2,339,782	-1,134,588	-2,659,219	-1,035,726	-2,243,006	-1,132,055	-1,515,926	-2,019,888	-1,431,170	711,314	-1,028,657	-891,016	-1,188,481	5,819,249	157,944	-3,244,731
investing activities
trademarks		0		-468	0
net cash from investing activities		0		-468	0	0	-1,366	-65,449	-4,423	-10,415,459	-22,871	0	-1,818	-16,402
financing activities
net proceeds from the issuances of common stock	1,221,982
net proceeds from the exercise of stock options
payments for taxes related to net share settlement of equity awards
net cash from financing activities	1,221,982	1,702,335	2,167,104	275,183	3,052,153	10,856,967		2,303,335	399,675	12,338,704	388,874	0	49,579	0	0	0	39,542
net increase in cash and cash equivalents		-637,447	1,031,876	-2,384,504	2,016,427
cash and cash equivalents, beginning of year
cash and cash equivalents, end of year
supplemental disclosure of cash flow information
cash paid during the year:
interest paid										0	0	0	0	0	-143	0	183
income taxes paid										0	0	0	-266,000	266,000	0	1,111	30,828
non-cash financing activities
payment of accrued liabilities with common stock	255,000	0	0	0	0	0	15,000
common stock issued for consulting services
adjustments to reconcile net income to net cash from operating activities:
changes in operating assets and liabilities:
net decrease in cash and cash equivalents	-656,024						2,277,670	721,960	-1,624,636		1,077,317	-1,028,657		-1,204,883		157,944	-3,205,189
cash and cash equivalents, beginning of period	28,598,445		0		0		0	0	17,958,989	0	0	3,028,791		5,580,244	0	0	9,907,691
cash and cash equivalents, end of period	27,942,421		1,031,876		2,016,427		2,277,670	721,960	16,334,353	492,075	1,077,317	2,000,134		4,375,361	5,174,471	480,020	4,705,577
cash paid during the period:
non-cash financing activities:
adjustments to reconcile net income from operations to net cash from operating activities:
net proceeds from the issuance of common stock			2,167,104						399,675
the accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
prepaid project costs
accrued legal settlement costs						0	-675,000
accumulated preferred stock dividend						116,662	194,405	183,532	180,228
exchanges of preferred stock series a and b to common stock
adjustments to reconcile net income from operations to net cash from operating activities
changes in operating working capital items
other receivables							675,000
net proceeds from issuances of common stock and exercise of stock options
cash paid during the period
conversion of series a convertible preferred stock to common stock and payment of paid-in-kind dividends to series a preferred stockholder							22,712	14,057	8,975
changes in operating working capital items:
net proceeds from issuances of common stock
supplemental disclosure of cash flow information:
patent write-off and impairment loss
amortization of patents
other receivable from joint venture								0	400,000
patent write-offs
patents and trademarks							-1,366
common stock issued for services and stock-based compensation
patent write-off
equity in income from joint venture
investment in joint venture
patent costs								-65,449	-4,423	-24,845	-22,871	0	0	-16,402
5
table of contents
operating activities:
investing activities:
financing activities:
write off of deferred financing costs
accounts receivable - fees and reimbursable project costs														1,038,592
net proceeds from the issuance of preferred stock
cash paid during the year
deemed dividend on issuance series b convertible preferred stock due to beneficial conversion feature
54
depreciation and amortization										4,800	6,465	6,951	5,398	6,004	8,126	456	3,011
unrealized gain on marketable securities
changes in non-cash operating working capital items:
accounts receivable - fees and reimburseable project costs										-138,704	1,514,577	-226,145
prepaid expenses and other assets
accounts payable, accrued liabilities and other current liabilities										88,639	-28,381	116,147	80,898	-1,596,398	-992,731	150,086	523,239
deferred revenue													0	0
marketable securities
property and equipment										0			-1,818
restricted cash										-319
non-cash financing activity:
grant of common stock for payment of accrued liabilities										85	1,001	702,651
stock based compensation										677,256	722,516	859,576		1,272,971
proceeds from the issuance of common stock - net of offering costs
redemption of common stock into treasury stock
non-cash financing activity
retirement of treasury stock
gain on marketable securities - available for sale
security deposits													5,062		0
deferred project costs - net													0	0
proceeds from issue of common shares													50,344	0	0	0	49,975
payments on notes payable and other													0	0	0	0	-10,433
increase in restricted cash													-765
loss on marketable securities - available for sale														0
reclassification of cash equivalents to marketable securities - available for sale															-452,580	322,076	-1,996,925
shares issued for other than cash for payment of expenses															1,713,233	1,423,375	1,363,803
amortization of deferred revenue - net
amortization of deferred project costs															1,862,309	1,775,437	1,609,129
realized loss on marketable securities
settlement expense
accounts receivable - reimbursable project costs
deferred project costs															-1,862,309	-1,723,708	-1,289,227
purchase of office equipment
other
non-cash transactions:
conversion of liabilities to equity
amortization of deferred revenue																0	-3,793,125
other current liabilities																-479,904	-713,780
non-cash transactions
unrealized loss on marketable securities – available for sale																	-131,723

We provide you with 20 years of cash flow statements for Lightbridge stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Lightbridge stock. Explore the full financial landscape of Lightbridge stock with our expertly curated income statements.

The information provided in this report about Lightbridge stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.